{"id":"https://openalex.org/W3198587100","doi":"https://doi.org/10.1016/j.esmoop.2021.100260","title":"Targeting HER2 in non-small-cell lung cancer (NSCLC): a glimpse of hope? An updated review on therapeutic strategies in NSCLC harbouring HER2 alterations","display_name":"Targeting HER2 in non-small-cell lung cancer (NSCLC): a glimpse of hope? An updated review on therapeutic strategies in NSCLC harbouring HER2 alterations","alternate_titles":[],"publication_year":2021,"publication_date":"2021-08-31","ids":{"openalex":"https://openalex.org/W3198587100","doi":"https://doi.org/10.1016/j.esmoop.2021.100260","mag":"3198587100","pmid":"https://pubmed.ncbi.nlm.nih.gov/34479034","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8414039"},"language":"en","primary_location":{"id":"doi:10.1016/j.esmoop.2021.100260","doi":"https://doi.org/10.1016/j.esmoop.2021.100260","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2021.100260","pdf_url":"http://www.esmoopen.com/article/S2059702921002222/pdf","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3198587100"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"http://www.esmoopen.com/article/S2059702921002222/pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056131577","display_name":"Mariona Riudavets","orcid":"https://orcid.org/0000-0002-5202-0631","observed_orcids":["https://orcid.org/0000-0002-5202-0631"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4405269973","display_name":"Fondation Gustave Roussy","ror":"https://ror.org/05rfnt234","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4405269973"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M. Riudavets","raw_affiliation_strings":["Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4405269973"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064234791","display_name":"Ivana Sullivan","orcid":"https://orcid.org/0000-0002-0434-3436","observed_orcids":["https://orcid.org/0000-0002-0434-3436","https://orcid.org/0000-0002-1924-6997"]},"institutions":[{"id":"https://openalex.org/I2801795740","display_name":"Hospital de Sant Pau","ror":"https://ror.org/059n1d175","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I2801795740"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"I. Sullivan","raw_affiliation_strings":["Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain","institution_ids":["https://openalex.org/I2801795740"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059383902","display_name":"Pamela Abdayem","orcid":"https://orcid.org/0000-0002-4477-3633","observed_orcids":["https://orcid.org/0000-0002-4477-3633"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4405269973","display_name":"Fondation Gustave Roussy","ror":"https://ror.org/05rfnt234","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4405269973"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. Abdayem","raw_affiliation_strings":["Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4405269973"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028596081","display_name":"David Planchard","orcid":"https://orcid.org/0000-0002-1565-8310","observed_orcids":["https://orcid.org/0000-0002-1565-8310"]},"institutions":[{"id":"https://openalex.org/I2801843802","display_name":"Institut Gustave Roussy","ror":"https://ror.org/0321g0743","country_code":"FR","type":"facility","lineage":["https://openalex.org/I2801843802"]},{"id":"https://openalex.org/I4405269973","display_name":"Fondation Gustave Roussy","ror":"https://ror.org/05rfnt234","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4405269973"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"D. Planchard","raw_affiliation_strings":["Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: David.PLANCHARD@gustaveroussy.fr","Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France. Electronic address: David.PLANCHARD@gustaveroussy.fr","institution_ids":["https://openalex.org/I2801843802"]},{"raw_affiliation_string":"Department of Cancer Medicine, Gustave Roussy Cancer Campus, Villejuif, France","institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4405269973"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5028596081"],"corresponding_institution_ids":["https://openalex.org/I2801843802","https://openalex.org/I4405269973"],"apc_list":{"value":3140,"currency":"USD","value_usd":3140},"apc_paid":{"value":3140,"currency":"USD","value_usd":3140},"fwci":4.5082,"has_fulltext":true,"cited_by_count":222,"citation_normalized_percentile":{"value":0.97058044,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"6","issue":"5","first_page":"100260","last_page":"100260"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12334","display_name":"Lung Cancer Research Studies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/her2-mutation","display_name":"HER2 mutation","score":0.8240000009536743},{"id":"https://openalex.org/keywords/her2-amplification","display_name":"HER2 amplification","score":0.9589999914169312},{"id":"https://openalex.org/keywords/her2-overexpression","display_name":"HER2 overexpression","score":0.8939999938011169},{"id":"https://openalex.org/keywords/her2-tyrosine-kinase-inhibitor","display_name":"HER2 tyrosine kinase inhibitor","score":0.9020000100135803},{"id":"https://openalex.org/keywords/poziotinib","display_name":"poziotinib","score":0.9700000286102295},{"id":"https://openalex.org/keywords/pyrotinib","display_name":"pyrotinib","score":1.0},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.8619999885559082},{"id":"https://openalex.org/keywords/pertuzumab","display_name":"pertuzumab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9129999876022339},{"id":"https://openalex.org/keywords/trastuzumab-emtansine","display_name":"trastuzumab emtansine","score":0.953000009059906},{"id":"https://openalex.org/keywords/trastuzumab-deruxtecan","display_name":"trastuzumab deruxtecan","score":0.996999979019165},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.6660000085830688},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitors","display_name":"immune checkpoint inhibitors","score":0.9020000100135803},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.6000000238418579}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.7737159729003906},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7185941934585571},{"id":"https://openalex.org/C2781164504","wikidata":"https://www.wikidata.org/wiki/Q1998021","display_name":"Pertuzumab","level":5,"score":0.6628847122192383},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.6133297085762024},{"id":"https://openalex.org/C2780586478","wikidata":"https://www.wikidata.org/wiki/Q4688818","display_name":"Afatinib","level":5,"score":0.5564019083976746},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5251312255859375},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.4843114912509918},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4537534713745117},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4155956506729126},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3635842204093933},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.2701886296272278},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.16215470433235168},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.11287268996238708}],"mesh":[{"descriptor_ui":"D000080044","descriptor_name":"Ado-Trastuzumab Emtansine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D002289","descriptor_name":"Carcinoma, Non-Small-Cell Lung","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008175","descriptor_name":"Lung Neoplasms","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":true},{"descriptor_ui":"D009154","descriptor_name":"Mutation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000235","qualifier_name":"genetics","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1016/j.esmoop.2021.100260","doi":"https://doi.org/10.1016/j.esmoop.2021.100260","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2021.100260","pdf_url":"http://www.esmoopen.com/article/S2059702921002222/pdf","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8414039","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC8414039/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"Text"},{"id":"pmid:34479034","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34479034","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO open","raw_type":"Journal Article"},{"id":"pmh:oai:ddd.uab.cat:270269","doi":null,"is_oa":true,"landing_page_url":"https://ddd.uab.cat/record/270269","pdf_url":"https://ddd.uab.cat/pub/artpub/2021/270269/270269.pdf","source":{"id":"https://openalex.org/S4306400380","display_name":"Dip\u00f2sit Digital de Documents de la UAB (Universitat Aut\u00f2noma de Barcelona)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I123044942","host_organization_name":"Universitat Aut\u00f2noma de Barcelona","host_organization_lineage":["https://openalex.org/I123044942"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article de revisi\u00f3"},{"id":"pmh:oai:recercat.cat:2072/465357","doi":null,"is_oa":true,"landing_page_url":"https://ddd.uab.cat/record/270269","pdf_url":null,"source":{"id":"https://openalex.org/S4306402147","display_name":"RECERCAT (Consorci de Serveis Universitaris de Catalunya)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210090028","host_organization_name":"Consorci de Serveis Universitaris de Catalunya","host_organization_lineage":["https://openalex.org/I4210090028"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Article de revisi\u00f3"}],"best_oa_location":{"id":"doi:10.1016/j.esmoop.2021.100260","doi":"https://doi.org/10.1016/j.esmoop.2021.100260","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2021.100260","pdf_url":"http://www.esmoopen.com/article/S2059702921002222/pdf","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","oarl","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307770","display_name":"AstraZeneca","ror":"https://ror.org/04r9x1a08"},{"id":"https://openalex.org/F4320307778","display_name":"Novartis","ror":"https://ror.org/02f9zrr09"},{"id":"https://openalex.org/F4320307779","display_name":"Roche","ror":"https://ror.org/00by1q217"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320310212","display_name":"Fundaci\u00f3n Alfonso Mart\u00edn Escudero","ror":"https://ror.org/02897ye82"},{"id":"https://openalex.org/F4320310441","display_name":"Boehringer Ingelheim","ror":"https://ror.org/00q32j219"},{"id":"https://openalex.org/F4320321625","display_name":"Daiichi-Sankyo","ror":"https://ror.org/027y26122"},{"id":"https://openalex.org/F4320332932","display_name":"Merck Sharp and Dohme","ror":"https://ror.org/004nn4n27"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3198587100.pdf","grobid_xml":"https://content.openalex.org/works/W3198587100.grobid-xml"},"referenced_works_count":98,"referenced_works":["https://openalex.org/W133672860","https://openalex.org/W1531524380","https://openalex.org/W1837870834","https://openalex.org/W1866981172","https://openalex.org/W1963541496","https://openalex.org/W1966071998","https://openalex.org/W1970232026","https://openalex.org/W1973033337","https://openalex.org/W1984007340","https://openalex.org/W1995653405","https://openalex.org/W2024772577","https://openalex.org/W2028837881","https://openalex.org/W2030375470","https://openalex.org/W2049449785","https://openalex.org/W2056579307","https://openalex.org/W2074725242","https://openalex.org/W2074961178","https://openalex.org/W2082664617","https://openalex.org/W2084993196","https://openalex.org/W2098532770","https://openalex.org/W2099032042","https://openalex.org/W2100439220","https://openalex.org/W2107562400","https://openalex.org/W2108523633","https://openalex.org/W2112854176","https://openalex.org/W2114095518","https://openalex.org/W2120627364","https://openalex.org/W2122706875","https://openalex.org/W2130043727","https://openalex.org/W2133208325","https://openalex.org/W2133867160","https://openalex.org/W2136028687","https://openalex.org/W2146274229","https://openalex.org/W2148527073","https://openalex.org/W2151016309","https://openalex.org/W2152494192","https://openalex.org/W2159192794","https://openalex.org/W2159967578","https://openalex.org/W2166199281","https://openalex.org/W2175694606","https://openalex.org/W2180481128","https://openalex.org/W2262992387","https://openalex.org/W2314772071","https://openalex.org/W2318605753","https://openalex.org/W2387397851","https://openalex.org/W2557036169","https://openalex.org/W2570599275","https://openalex.org/W2616596696","https://openalex.org/W2735084022","https://openalex.org/W2736802184","https://openalex.org/W2736996422","https://openalex.org/W2752545514","https://openalex.org/W2760931533","https://openalex.org/W2767597066","https://openalex.org/W2775672838","https://openalex.org/W2783112448","https://openalex.org/W2785610956","https://openalex.org/W2800964883","https://openalex.org/W2801651204","https://openalex.org/W2810059108","https://openalex.org/W2885615830","https://openalex.org/W2889957730","https://openalex.org/W2891814014","https://openalex.org/W2892284712","https://openalex.org/W2892314886","https://openalex.org/W2895926103","https://openalex.org/W2896602377","https://openalex.org/W2896939494","https://openalex.org/W2898137622","https://openalex.org/W2898351957","https://openalex.org/W2898375329","https://openalex.org/W2898457249","https://openalex.org/W2907907709","https://openalex.org/W2913258427","https://openalex.org/W2913472940","https://openalex.org/W2915968104","https://openalex.org/W2942867242","https://openalex.org/W2943729639","https://openalex.org/W2946166987","https://openalex.org/W2947410094","https://openalex.org/W2977889895","https://openalex.org/W2991626449","https://openalex.org/W3000445801","https://openalex.org/W3013150216","https://openalex.org/W3013632168","https://openalex.org/W3032438306","https://openalex.org/W3038770224","https://openalex.org/W3088045239","https://openalex.org/W3088586143","https://openalex.org/W3089112132","https://openalex.org/W3115703756","https://openalex.org/W3135105663","https://openalex.org/W3136317587","https://openalex.org/W3138654081","https://openalex.org/W6605423069","https://openalex.org/W6674616001","https://openalex.org/W6676704494","https://openalex.org/W6682156422"],"related_works":["https://openalex.org/W4293659721","https://openalex.org/W7133218606","https://openalex.org/W4318204989","https://openalex.org/W4415740738","https://openalex.org/W4411458258","https://openalex.org/W3158369241","https://openalex.org/W7140208285","https://openalex.org/W4303832735","https://openalex.org/W4415116770","https://openalex.org/W3215702511"],"abstract_inverted_index":{"Non-small-cell":[0],"lung":[1],"cancer":[2],"(NSCLC)":[3],"harbouring":[4],"HER2":[5,17,91,108,230],"alterations":[6],"is":[7,201],"now":[8],"considered":[9],"a":[10,52,117,177,217],"distinct":[11,187],"molecular":[12,231],"subtype.":[13],"The":[14,134],"activation":[15],"of":[16,28,160,173,184,189,211],"in":[18,55,120,152,227],"NSCLC":[19,57,123,228],"occurs":[20],"via":[21],"three":[22],"mechanisms,":[23],"i.e.":[24],"gene":[25,30],"mutation":[26],"(1%-4%":[27],"cases),":[29],"amplification":[31],"(2%-5%)":[32],"and":[33,40,89,96,113,131,150,162,205,220],"protein":[34],"overexpression":[35],"(2%-30%),":[36],"with":[37,59,94,125,154,157,186,194,229],"different":[38],"prognostic":[39],"predictive":[41],"outcomes.":[42],"So":[43],"far,":[44],"non-selective":[45],"tyrosine":[46],"kinase":[47],"inhibitors":[48],"(TKIs)":[49],"have":[50,115],"shown":[51,116],"minor":[53],"benefit":[54],"HER2-mutant":[56,121,155],"patients":[58,153],"objective":[60],"response":[61,126,158],"rates":[62,127,159],"(ORRs)":[63],"ranging":[64],"from":[65,139,180],"0%":[66],"to":[67,74,77,129,170],"19%.":[68],"Trastuzumab-based":[69],"chemotherapy":[70,78],"was":[71],"not":[72],"found":[73],"be":[75],"superior":[76],"alone":[79],"[median":[80],"progression-free":[81],"survival":[82],"(PFS)":[83],"6.1":[84],"versus":[85],"7":[86],"months,":[87],"respectively]":[88],"dual":[90],"antibody":[92],"blockade":[93],"trastuzumab":[95],"pertuzumab":[97],"had":[98],"limited":[99],"efficacy":[100],"(ORR":[101],"13%-21%).":[102],"In":[103],"contrast,":[104],"novel":[105],"more":[106],"selective":[107],"TKIs":[109,196],"such":[110,191],"as":[111,192],"poziotinib":[112],"pyrotinib":[114],"promising":[118],"activity":[119],"pre-treated":[122],"patients,":[124],"up":[128],"38%":[130],"44%,":[132],"respectively.":[133,164],"most":[135],"encouraging":[136],"data":[137],"come":[138],"phase":[140],"II":[141],"studies":[142],"that":[143],"evaluated":[144],"the":[145,171,208,224],"antibody-drug":[146],"conjugates":[147],"(ADCs)":[148],"ado-trastuzumab-emtansine":[149],"trastuzumab-deruxtecan":[151],"NSCLC,":[156],"50%":[161],"62%,":[163],"These":[165],"agents":[166,185],"are":[167],"bringing":[168],"hope":[169],"management":[172],"HER2-altered":[174],"NSCLC.":[175,213],"Moreover,":[176],"paradigm":[178],"shift":[179],"monotherapies":[181],"towards":[182],"combinations":[183],"mechanisms":[188],"action,":[190],"ADCs":[193],"irreversible":[195],"or":[197],"immune":[198],"checkpoint":[199],"inhibitors,":[200],"already":[202],"taking":[203],"place":[204],"will":[206],"change":[207],"therapeutic":[209,225],"landscape":[210],"HER2-driven":[212],"This":[214],"paper":[215],"provides":[216],"practical,":[218],"concise":[219],"updated":[221],"review":[222],"on":[223],"strategies":[226],"alterations.":[232]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3198587100","counts_by_year":[{"year":2026,"cited_by_count":40},{"year":2025,"cited_by_count":58},{"year":2024,"cited_by_count":50},{"year":2023,"cited_by_count":43},{"year":2022,"cited_by_count":30},{"year":2021,"cited_by_count":1}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2021-09-13T00:00:00"}
